Mechanism of Relaxations to Dendroaspis Natriuretic Peptide in Canine Coronary Arteries
- 1 April 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 35 (4) , 614-618
- https://doi.org/10.1097/00005344-200004000-00015
Abstract
Experiments were designed to determine mechanisms by which Dendroaspis natriuretic peptide (DNP) causes relaxations in coronary arteries. Rings of canine left circumflex artery with and without endothelium were suspended in organ chambers filled with Krebs-Ringer bicarbonate solution (37°C, bubbled with 95% O2/5% CO2). Concentration-response curves to DNP (10−10 to 3 × 10−7 M) were obtained in arteries contracted with prostaglandin (PGF2α, 2 × 10−6 M), either in the absence or the presence of C-ANP (10−6 M) to inhibit natriuretic clearance receptors; indomethacin to inhibit cyclo-oxygenase (INDO, 10−5 M), N G-monomethyl-L-arginine to inhibit production of nitric oxide (L-NMMA; 10−4 M), HS-142-1 to inhibit particulate guanylate cyclase (10−5 M); 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one to inhibit soluble guanylate cyclase (ODQ; 10−5 M), or tetraethylammonium to inhibit potassium channels (TEA; 10−3 or 10−2 M). Relaxations to DNP were greater in rings with than in those without endothelium. C-ANP significantly attenuated relaxations to DNP only in rings with endothelium. HS-146-1 but not INDO, L-NMMA, ODQ, and TEA significantly reduced relaxations to DNP in rings with and without endothelium contracted with PGF2α. These results suggest that the endothelium augments inhibitory effects of DNP and that natriuretic clearance receptors mediate this component of the response to DNP in canine coronary arteries. In addition, relaxations to DNP in canine arterial smooth muscle involve activation of particulate guanylate cyclase but not hyperpolarization.Keywords
This publication has 16 references indexed in Scilit:
- Presence of Dendroaspis Natriuretic Peptide-Like Immunoreactivity in Human Plasma and Its Increase During Human Heart FailureMayo Clinic Proceedings, 1999
- Specificity of C-Type and Atrial Natriuretic Peptides in Human Blood VesselsEndothelium, 1996
- Renal Effects of High-Dose Natriuretic Peptide Receptor Blockade in Rats With Congestive Heart FailureCirculation Research, 1995
- Genetic Decreases in Atrial Natriuretic Peptide and Salt-Sensitive HypertensionScience, 1995
- Vascular Actions of C-Type Natriuretic Peptide in Isolated Porcine Coronary Arteries and Coronary Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1994
- Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.Journal of Clinical Investigation, 1994
- Modulation of exogenous and endogenous atrial natriuretic peptide by a receptor inhibitor.Hypertension, 1994
- Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide.Journal of Clinical Investigation, 1993
- Selective Activation of the B Natriuretic Peptide Receptor by C-Type Natriuretic Peptide (CNP)Science, 1991
- Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes.Hypertension, 1990